Lam Research reported $26.1B of revenue over the trailing twelve months, +33% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $26.1B (to Q1 2027). Net income: $8.45B, trailing twelve months to Q1 2027. Free cash flow: $6.54B, trailing twelve months to Q1 2027. Operating margin: 37%, trailing twelve months to Q1 2027.

LRCXLam Research

Technology

$230.28+62% 1Y

$230.28

$139.1052 weeks$434.22

LRCX as reported

Lam Research reported $26.1B of revenue over the trailing twelve months, +33% on the year before. 11 reported series are charted on this page, each one as filed.

$26.1B

Revenue, trailing twelve months · to Q1 2027 · +33% against the twelve months before

Net income: $8.45B
Net income · +45% year on year · trailing twelve months to Q1 2027
Free cash flow: $6.54B
Free cash flow · +18% year on year · trailing twelve months to Q1 2027
Operating margin: 37%
Operating margin · trailing twelve months to Q1 2027

Details›

Every series Ryufin has for LRCX, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$26.1B	+33%	Q1 2027
Net income	$8.45B	+45%	Q1 2027
EPS	$6.71	+48%	Q1 2027
Gross margin	51%	n/a	Q1 2027
Operating margin	37%	n/a	Q1 2027
Net margin	32%	n/a	Q1 2027
ROE	61%	n/a	Q1 2027
ROA	31%	n/a	Q1 2027
ROIC	65%	n/a	Q1 2027
Free cash flow	$6.54B	+18%	Q1 2027
P/E	34.3	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.